13D Filings
Home
FAQ
ENvue Medical, Inc.
NAOV
Amendment
Ownership

6.50%

Total Shares

240,000

Issuer CIK

1326706

Event Date

Jan 13, 2026

Accepted

Apr 17, 2026, 04:57 PM

SEC EDGARView Original Filing
Reporting Persons (1)
NameType% of ClassAggregateSole VotingShared Voting
Glibert Christian Michael
Individual
6.50%240,00000
Disclosure Items (4)

Security Title

Common Stock, par value $0.001 per share

Issuer Name

ENvue Medical, Inc.

Issuer Address

969 PRUITT AVE,, TYLER, TX, 77569

This Amendment No. 1 to Schedule 13D is being filed to report a material change in the Reporting Person's percentage of beneficial ownership of the Issuer's Common Stock. Since the filing of the initial Schedule 13D on February 11, 2026, the Issuer's total shares outstanding increased from 1,088,192 to 3,700,908, as reported in the Issuer's Annual Report on Form 10-K filed on April 15, 2026. This increase in outstanding shares resulted in the dilution of the Reporting Person's beneficial ownership from approximately 22.1 percent to approximately 6.5 percent. The Reporting Person has not acquired or disposed of any shares of Common Stock since the initial filing. The Reporting Person continues to hold the shares for investment purposes and may, from time to time, purchase additional shares or dispose of existing shares in the open market or in private transactions, depending on market conditions and other factors.

Percentage of Class

240,000 shares which is 6.5% of shares

Number of Shares

Sole power to vote: 240,000 Shared power to vote: 0 Sole power to dispose: 240,000 Shared power to dispose: 0

Transactions

none

Shareholders

not applicable

The information set forth in Item 6 of the initial Schedule 13D is incorporated herein by reference. There have been no material changes to the contracts or arrangements previously reported.